Frontline Plc - Share Issue/Capital Change 2025

FRO - Grant of synthetic options

Frontline plc ("Frontline" or the "Company") hereby announces that 362,284

synthetic options have today been granted to management and employees of the

Company. The synthetic options will have a five-year term expiring May

27, 2030, and will vest over a three-year vesting period as follows:

* 1/3 of the synthetic options will vest on May 27, 2026

* 1/3 of the synthetic options will vest on May 27, 2027

* 1/3 of the synthetic options will vest on May 27, 2028

The exercise price of the synthetic options is USD 16.8 being the volume-

weighted average price of the share the last 30 days prior to grant. The

exercise price will further be adjusted for any distribution of dividends made

before the relevant synthetic options are exercised. The synthetic options

granted to the CEO and the CFO are subject to a cap on maximum annual gain equal

to two times the annual base salary at the time of exercise of the synthetic

options.

The synthetic options will be settled in cash based on the difference between

the market price of the Company's shares and the exercise price on the date of

exercise.

The synthetic options have been granted according to the rules of the Company's

synthetic option scheme approved by the Board of Directors of the Company.

Please see the attached forms of notification of transactions by primary

insiders for the synthetic options.

May 27, 2025

The Board of Directors

Frontline plc

Limassol, Cyprus

This notification has been publicly disclosed in accordance with Article 19 of

the Market Abuse Regulation and section 5-12 of the Norwegian Securities Trading

Act.

AI assistant